ArticleCancer research communications2024

Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.

Maria C White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.